An appeals court has reversed a lower court ruling against Teva's (TEVA -0.5%) Cephalon unit...

|By:, SA News Editor

An appeals court has reversed a lower court ruling against Teva's (TEVA -0.5%) Cephalon unit related to its generic muscle-relaxant Amrix. The court had initially found in favor of Mylan (MYL -0.3%) and Par Pharmaceutical (PRX -0.3%), who had successfully argued that patents held by Cephalon were invalid.